SCHEMBL6273257

SCHEMBL6273257

CCOC(=O)c1cc2c(C)c(Oc3ccc(O)c(C(=O)N(C)C4CCC4)c3)c(C)cc2[nH]1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE3B Q13370 4/20 0.37
▸ PDE3A Q14432 4/20 0.37
▸ THRA P10827 1/20 0.37
▸ THRB P10828 1/20 0.37
▸ ALDH1A1 P00352 7/20 0.36
▸ RAB9A P51151 6/20 0.36
▸ KDM4E B2RXH2 6/20 0.36
▸ HPGD P15428 6/20 0.36
▸ NPC1 O15118 4/20 0.36
▸ LMNA P02545 3/20 0.36
▸ HTT P42858 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ MAPT P10636 5/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ GLA P06280 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ TSHR P16473 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1642351 0.90 THRB (0.47) PDE3BPDE3ATHRATHRBMEN1
SCHEMBL6272516 0.83 THRB (0.36) PDE3BPDE3ATHRATHRBALDH1A1
SCHEMBL6270958 0.79 THRB (0.51) THRATHRBALDH1A1RAB9AKDM4E
SCHEMBL6270950 0.78 ALDH1A1 (0.44) THRATHRBALDH1A1RAB9AKDM4E
SCHEMBL6270951 0.77 THRA (0.60) THRATHRB
SCHEMBL6274786 0.77 THRA (0.52) THRATHRBALDH1A1RAB9AKDM4E
SCHEMBL6268671 0.75 THRA (0.50) PDE3BPDE3ATHRATHRBALDH1A1
SCHEMBL6275027 0.75 THRB (0.39) THRATHRBRAB9AHPGDNPC1
SCHEMBL6660244 0.74 THRA (0.53) THRATHRB
SCHEMBL7058944 0.74 HPGD (0.43) THRATHRBALDH1A1RAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1297833-B1 Indole carboxylic acids as thyroid receptor ligands PFIZER PROD INC (US) 2005-12-21 — — EP disclosed
US-6723744-B2 FOR THERAPY OF OBESITY, OVERWEIGHT CONDITION, HYPERLIPIDEMIA, GLAUCOMA, CARDIAC ARRHYTHMIAS, SKIN DISORDER, THYROID DISEASE, HYPOTHYROIDISM, THYROID CANCER, DIABETES, ATHEROSCLEROSIS, HYPERTENSION, CORONARY HEART DISEASE, HYPERCHOLESTEREMIA PFIZER, INC. 2004-04-20 — — US disclosed
US-20030078289-A1 Indole carboxylic acids as thyroid receptor ligands ASPNES GARY E (US) 2003-04-24 — — US disclosed
EP-1297833-A1 Indole carboxylic acids as thyroid receptor ligands Pfizer Products Inc. (US) 2003-04-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078289-A1 Indole carboxylic acids as thyroid receptor ligands THRA, MC1R, THRB PDE3B 4325/4885PDE3A 4125/4885THRA 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback